Glycosaminoglycan treatment in glomerulonephritis? An interesting option to investigate.


Patients with primary and secondary chronic glomerular diseases are at significant risk for progression to end-stage renal disease. Unfortunately the treatment armamentarium is relatively limited in terms both of available agents and of specificity. Experimental evidence supports the idea that heparin-derived agents and glycosaminoglycans (GAGs) favorably… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.